Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion description "[Significantly, pharmacological blockade of the ?(2A)AR by a clinically used antagonist reduces AD-related pathology and ameliorates cognitive deficits in an AD transgenic model, suggesting that repurposing clinical ?(2A)R antagonists would be an effective therapeutic strategy for AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion evidence source_evidence_literature NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion SIO_000772 25404298 NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion wasDerivedFrom befree-2016 NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion wasGeneratedBy ECO_0000203 NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- befree-2016 importedOn "2016-02-19" NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.